Abbott GW .

	Figure 1. KChIP2b differentially augments Kv4.3L and Kv4.3S current magnitude. (A) Exemplar current traces recorded at +40 mV (voltage protocol inset) from Xenopus oocytes 36–40 h after injection of 0.2 ng cRNA encoding Kv4.3L or Kv4.3S, with or without 1 ng KChIP2b (n = 14–18). Insets: left, scale bars; right, Voltage clamp protocol. Zero current level indicated by dashed line. (B) Mean ± SEM peak current magnitude at +40 mV for currents recorded as in (A) but with 0.04–5 ng Kv4.3L or S cRNA, with or without 1 or 5 ng KChIP2b cRNA, injected per oocytes, as indicated (n = 14–37). **P < 0.01 vs. all other groups with similar quantity of cRNA injected, by ANOVA followed by Tukey's HSD test. (C) Sequence alignment (Clustal TCoffee) of human Kv4.2, Kv4.3L and Kv4.3S protein sequences in the S6 to C-terminal region, including the segment missing in Kv4.3s (underlined red). (D) Exemplar current traces recorded at +40 mV (voltage protocol as in panel A) from Xenopus oocytes 36–40 h after injection of 1 ng cRNA encoding hKv4.2 with or without 5 ng hKChIP2b cRNA (n = 16–18). Scale bar inset. Zero current level indicated by dashed line. (E) Mean ± SEM peak current magnitude at +40 mV for currents recorded as in (E) (n = 16–18). ***P < 0.0001 between groups. (F) Comparison of Kv4.x current augmentation by hKChIP2b, analyzed from data in panels B and F (1 ng Kv4.x, 5 ng hKChP2b cRNA; n = 16–37).
	Figure 2. KChIP2b differentially affects Kv4.3L and Kv4.3S inactivation rate and voltage dependence. (A) Exemplar current traces recorded from Xenopus oocytes 36–48 h after injection of 1 ng cRNA (as indicated) encoding Kv4.3L or Kv4.3S alone (black, n = 13–14) or in addition to 5 ng cRNA encoding KChIP2 (red, n = 13–31). Insets: right, Voltage clamp protocol; left, scale bars. Zero current level indicated by dashed line. (B) Mean ± SEM peak current/voltage relationship for currents as in (A); n-values as in (A). (C) Box plots showing individual and mean ± SEM values for fast and slow τ of inactivation, and relative amplitude of the fast component (double exponential fit), of Kv4.3L vs. Kv4.3S, recorded as in (A). n = 13–14. NS, P > 0.05. (D) Box plots showing individual and mean ± SEM values for τ of inactivation (single exponential fit) of Kv4.3L vs. Kv4.3S, with KChIP2 co-expression. Currents recorded as in (A); n = 13–14. ***P < 1 × 10−15. (E) Upper, exemplar current trace recorded using a steady-state inactivation protocol, from Xenopus oocytes 36–48 h after injection of cRNA encoding Kv4.3L (1 ng) and KChIP2 (5 ng). Insets: left, Voltage clamp protocol; right, scale bars. Zero current level indicated by dashed line. Lower, mean ± SEM fraction of available channels/voltage relationship for Kv4.3L vs. Kv4.3S, with/without KChIP2b; currents recorded as in (E); n = 6–8. (F) Upper, exemplar current trace recorded using an inactivation recovery protocol, from Xenopus oocytes 48 h after injection of cRNA encoding Kv4.3L (1 ng) and KChIP2 (5 ng). Insets: left and lower right, scale bars; center, voltage clamp protocol. Zero current level indicated by dashed line. Lower, mean ± SEM fractional recovery from inactivation/recovery time for Kv4.3L vs. Kv4.3S, with/without KChIP2b; recorded as in protocol above; n = 4–6.
	Figure 3. KCNE1 differentially affects Kv4.3L and Kv4.3S function with/without KChIP2b. (A) Mean ± SEM peak current/voltage relationship for current traces recorded from Xenopus oocytes 48 h after injection of cRNA encoding Kv4.3L or Kv4.3S (1 ng) with KCNE1 (5 ng), with or without KChIP2b (5 ng; n = 9–17). Inset: Voltage clamp protocol. **P < 0.01 compared to other currents at +40 mV. (B) Box plots showing individual and mean ± SEM values for τ of fast and slow components, and relative amplitude, of fast inactivation (double exponential fit) of Kv4.3L-KCNE1 vs. Kv4.3S-KCNE1 currents recorded as in (A); n = 7–11. *P < 0.05; **P < 0.01; NS, P > 0.05. (C) Box plot showing individual and mean ± SEM values for τ of Kv4.3L-KCNE1-KChIP2b vs. Kv4.3S-KCNE1-KChIP2b inactivation (single exponential fit) for currents recorded as in (B); n = 8–17. **P < 0.01. (D) Mean ± SEM fraction of available channels/voltage relationship for Kv4.3L-KCNE1-KChIP2b vs. Kv4.3S-KCNE1-KChIP2b currents; voltage protocol upper right inset; n = 6. (E) Mean ± SEM fractional recovery from inactivation/recovery time for Kv4.3L-KCNE1 vs. Kv4.3S-KCNE1 with (n = 6) or without (n = 3–4) KChIP2b; voltage protocol upper right inset.
	Figure 4. KCNE2 differentially affects Kv4.3L and Kv4.3S function with/without KChIP2b. (A) Mean ± SEM peak current/voltage relationship for current traces recorded from Xenopus oocytes 36–48 h after injection of cRNA encoding Kv4.3L or Kv4.3S (1 ng) with KCNE2 (5 ng), with or without KChIP2 (5 ng; n = 14–18). Inset: Voltage clamp protocol. ***P < 0.001 compared to Kv4.3L-KChIP2-KCNE2 at +40 mV. (B) Box plot showing individual and mean ± SEM values for τ of inactivation (single exponential fit) for currents recorded as in (A); n = 14–18. NS, P > 0.05; ***P < 5 × 10−14. (C) Mean ± SEM fraction of available channels/voltage relationship for Kv4.3L-KCNE2 vs. Kv4.3S-KCNE2 (upper) and Kv4.3L-KCNE2-KChIP2 vs. Kv4.3S-KCNE2-KChIP2 (lower) currents; voltage protocol upper right inset; n = 6. (D) Mean ± SEM fractional recovery from inactivation/recovery time for Kv4.3L-KCNE2 vs. Kv4.3S-KCNE2 (upper) and Kv4.3L-KCNE2-KChIP2 vs. Kv4.3S-KCNE2-KChIP2 (lower) currents; voltage protocol upper inset; n = 5–7.
	Figure 5. KCNE3 differentially affects Kv4.3L and Kv4.3S current magnitude with KChIP2b. (A) Mean ± SEM peak current/voltage relationship for current traces recorded from Xenopus oocytes 36–48 h after injection of cRNA encoding Kv4.3L or Kv4.3S (1 ng) with KCNE3 (5 ng) with or without KChIP2 (5 ng; n = 11–20). Inset: Voltage clamp protocol. ***P < 0.001 compared to other currents at +40 mV. (B) Box plots showing individual and mean ± SEM values for τ of fast and slow components, and relative amplitude, of fast inactivation (double exponential fit) of Kv4.3L-KCNE3 vs. Kv4.3S-KCNE3 currents recorded as in (A); n = 10–13. NS, P > 0.05. (C) Box plot showing individual and mean ± SEM values for τ of Kv4.3L-KCNE3-KChIP2 vs. Kv4.3S-KCNE3-KChIP2 inactivation (single exponential fit) for currents recorded as in (B); n = 11–15. NS, P > 0.05. (D) Mean ± SEM fraction of available channels/voltage relationship for Kv4.3L-KCNE3 vs. Kv4.3S-KCNE3 with/without KChIP2; voltage protocol upper right inset; n = 5–7. (E) Mean ± SEM fractional recovery from inactivation/recovery time for Kv4.3L-KCNE3-KChIP2 vs. Kv4.3S-KCNE3-KChIP2; voltage protocol upper inset; n = 4–7.
	Figure 6. KCNE4 differentially affects Kv4.3L and Kv4.3S function with KChIP2b. (A) Mean ± SEM peak current/voltage relationship for current traces recorded from Xenopus oocytes 36–48 h after injection of cRNA encoding Kv4.3L (filled squares) and (circles)/or (open squares) Kv4.3S (1 ng), with KCNE4 (5 ng), with/without KChIP2 (5 ng; n = 10–17). Lower right inset: Voltage clamp protocol. **P < 0.01 compared to all other currents at +40 mV, by one-way ANOVA with post-hoc Tukey HSD-test. Upper right inset: no effect on current density of individually increasing Kv4.3L (red columns) or Kv4.3S (open columns) cRNA injected, from 1 to 5 ng per oocyte, when co-injected with KCNE4S and KChIP2b cRNA (n = 11–17). NS = P > 0.05 by one-way ANOVA with post-hoc Tukey HSD-test; all other group comparisons P < 0.01. (B) Box plot showing individual and mean ± SEM values for τ of inactivation (single exponential fit) for Kv4.3L and / or Kv4.3S co-expressed with KCNE4 and KChIP2; n = 7–15. ***P < 5 × 10−6 vs. other groups; other comparisons P > 0.05. (C) Mean ± SEM fraction of available channels/voltage relationship for Kv4.3L and/or Kv4.3S co-expressed with KCNE4 and KChIP2; voltage protocol upper right inset; n = 5–6. (D) Mean ± SEM fractional recovery from inactivation/recovery time for Kv4.3L and/or Kv4.3S co-expressed with KCNE4 and KChIP2; voltage protocol upper inset; n = 5–6. Arrow, overshoot following recovery from inactivation.
	Figure 7. KCNE5 differentially affects Kv4.3L and Kv4.3S function. (A) Mean ± SEM peak current/voltage relationship for current traces recorded from Xenopus oocytes 36–48 h after injection of cRNA encoding Kv4.3L or Kv4.3S (1 ng) with KCNE5 (1–5 ng) with/without KChIP2b (5 ng; n = 6–12). *P < 0.05 between Kv4.3L and Kv4.3S with similar β subunits. Inset: Voltage clamp protocol. (B) Box plots showing individual and mean ± SEM values for τ of fast and slow components, and relative amplitude, of fast inactivation (double exponential fit) of Kv4.3L-KCNE5 vs. Kv4.3S-KCNE5 currents recorded as in (A); n = 5–7. NS, P > 0.05. (C) Box plot showing individual and mean ± SEM values for τ of inactivation (single exponential fit) for Kv4.3L vs. Kv4.3S co-expressed with KCNE5 and KChIP2; n = 9–12. ***P < 5 × 10−8. (D) Mean ± SEM fraction of available channels/voltage relationship for Kv4.3L-KCNE5 vs. Kv4.3S-KCNE5 channels with (n = 5–12) or without (n = 5–9) KChIP2; voltage protocol inset. (E) Mean ± SEM fractional recovery from inactivation/recovery time for Kv4.3L-KCNE5 vs. Kv4.3S-KCNE5 channels with (n = 7–8) or without (n = 5–6) KChIP2; voltage protocol inset.
	Figure 8. Kv4.3S-KChIP2 function is modified by a peptide corresponding to Kv4.3L residues 488–506. (A) Mean ± SEM peak current at 40 mV for current traces recorded from Xenopus oocytes 48–72 h after injection of 1.5 ng cRNA each encoding the following: Kv4.2 with (n = 10) or without (n = 7–8) KChIP2; Kv4.3L with (n = 13–20) or without (n = 8–12) KChIP2; Kv4.3S with (n = 13–17) or without (n = 8) KChIP2, 30–90 min following injection of L peptide (red columns) or control peptide (open columns; final concentration 25 μM). *P < 0.05; all other same-subunit combination comparisons P > 0.05. (B) Mean ± SEM inactivation τ at 40 mV for current traces recorded from Xenopus oocytes 48–72 h after injection of cRNAs as in (A). *P < 0.05; all other same-subunit combination comparisons P > 0.05.
	Figure 9. Subunit cRNA ratios mimicking those in human HF Kv4.3S- and KChIP2-dependently reduce current. (A) Mean ± SEM peak current/Voltage relationship for current traces recorded from Xenopus oocytes 48–72 h after injection of cRNAs as indicated (n = 12–15; ***P < 0.001, ****P < 1 × 10−5 vs. current magnitude for other groups at +40 mV). Lower right inset: Voltage clamp protocol. (B) Box plot showing individual and mean ± SEM values for τ of inactivation (single exponential fit) for currents generated as in (A), symbols as in (A) (n = 12–15; *P < 0.05, ****P < 1 × 10−5). (C) Averaged current traces elicited by ventricular action potential-like Voltage protocol (center) recorded in oocytes expressing channel subunit ratios as in (A), line colors as in (A), scaled to mean current magnitudes as in (A) (left) or normalized for easier comparison of gating kinetics (right). Each trace is an average of 120–300 raw traces recorded from 4 to 10 cells.

Abbott, The KCNE2 K⁺ channel regulatory subunit: Ubiquitous influence, complex pathobiology. 2015, Pubmed

Abbott, The KCNE2 K⁺ channel regulatory subunit: Ubiquitous influence, complex pathobiology. 2015, Pubmed
Abbott, MiRP2 forms potassium channels in skeletal muscle with Kv3.4 and is associated with periodic paralysis. 2001, Pubmed , Xenbase
Abbott, A superfamily of small potassium channel subunits: form and function of the MinK-related peptides (MiRPs). 1998, Pubmed
Abbott, Novel exon 1 protein-coding regions N-terminally extend human KCNE3 and KCNE4. 2016, Pubmed , Xenbase
Abbott, Phosphorylation and protonation of neighboring MiRP2 sites: function and pathophysiology of MiRP2-Kv3.4 potassium channels in periodic paralysis. 2006, Pubmed
Abbott, KCNE1 and KCNE3: The yin and yang of voltage-gated K(+) channel regulation. 2016, Pubmed
Abbott, KCNE4 and KCNE5: K(+) channel regulation and cardiac arrhythmogenesis. 2016, Pubmed
An, Modulation of A-type potassium channels by a family of calcium sensors. 2000, Pubmed , Xenbase
Bähring, Conserved Kv4 N-terminal domain critical for effects of Kv channel-interacting protein 2.2 on channel expression and gating. 2001, Pubmed
Barghaan, Dynamic coupling of voltage sensor and gate involved in closed-state inactivation of kv4.2 channels. 2009, Pubmed , Xenbase
Barghaan, Role of N-terminal domain and accessory subunits in controlling deactivation-inactivation coupling of Kv4.2 channels. 2008, Pubmed
Barhanin, K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current. 1996, Pubmed , Xenbase
Beuckelmann, Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal heart failure. 1993, Pubmed
Callsen, Contribution of N- and C-terminal Kv4.2 channel domains to KChIP interaction [corrected]. 2005, Pubmed
Cohn, Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. 1986, Pubmed
Delpón, Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome. 2008, Pubmed
Deschênes, Modulation of Kv4.3 current by accessory subunits. 2002, Pubmed
Dixon, Role of the Kv4.3 K+ channel in ventricular muscle. A molecular correlate for the transient outward current. 1996, Pubmed
Dougherty, Gating charge immobilization in Kv4.2 channels: the basis of closed-state inactivation. 2008, Pubmed
Giudicessi, Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome. 2011, Pubmed
Grunnet, KCNE4 is an inhibitory subunit to Kv1.1 and Kv1.3 potassium channels. 2003, Pubmed , Xenbase
Han, C-terminal domain of Kv4.2 and associated KChIP2 interactions regulate functional expression and gating of Kv4.2. 2006, Pubmed
Jiang, Dynamic partnership between KCNQ1 and KCNE1 and influence on cardiac IKs current amplitude by KCNE2. 2009, Pubmed
Johns, Suppression of neuronal and cardiac transient outward currents by viral gene transfer of dominant-negative Kv4.2 constructs. 1997, Pubmed
Kääb, Molecular basis of transient outward potassium current downregulation in human heart failure: a decrease in Kv4.3 mRNA correlates with a reduction in current density. 1998, Pubmed
Kanda, KCNE1 and KCNE2 inhibit forward trafficking of homomeric N-type voltage-gated potassium channels. 2011, Pubmed
Kanda, KCNE1 and KCNE2 provide a checkpoint governing voltage-gated potassium channel α-subunit composition. 2011, Pubmed
Kong, Isolation and characterization of the human gene encoding Ito: further diversity by alternative mRNA splicing. 1998, Pubmed
Kuo, A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of I(to) and confers susceptibility to ventricular tachycardia. 2001, Pubmed
Levy, The membrane protein MiRP3 regulates Kv4.2 channels in a KChIP-dependent manner. 2010, Pubmed
Liu, Co-expression of KCNE2 and KChIP2c modulates the electrophysiological properties of Kv4.2 current in COS-7 cells. 2008, Pubmed
McDonald, A minK-HERG complex regulates the cardiac potassium current I(Kr). 1997, Pubmed , Xenbase
Mozaffarian, Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. 2016, Pubmed
Näbauer, Characteristics of transient outward current in human ventricular myocytes from patients with terminal heart failure. 1993, Pubmed
Ohno, KCNE5 (KCNE1L) variants are novel modulators of Brugada syndrome and idiopathic ventricular fibrillation. 2011, Pubmed
Ohya, Molecular cloning and tissue distribution of an alternatively spliced variant of an A-type K+ channel alpha-subunit, Kv4.3 in the rat. 1997, Pubmed
Po, Mechanism of alpha-adrenergic regulation of expressed hKv4.3 currents. 2001, Pubmed
Radicke, Functional modulation of the transient outward current Ito by KCNE beta-subunits and regional distribution in human non-failing and failing hearts. 2006, Pubmed
Rhodes, KChIPs and Kv4 alpha subunits as integral components of A-type potassium channels in mammalian brain. 2004, Pubmed
Roger, Epidemiology of heart failure. 2013, Pubmed
Sanguinetti, Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. 1996, Pubmed , Xenbase
Serôdio, Cloning of a novel component of A-type K+ channels operating at subthreshold potentials with unique expression in heart and brain. 1996, Pubmed , Xenbase
Serôdio, Identification of molecular components of A-type channels activating at subthreshold potentials. 1994, Pubmed , Xenbase
Stevenson, Sudden death prevention in patients with advanced ventricular dysfunction. 1993, Pubmed
Vega-Saenz de Miera, Cloning of ShIII (Shaw-like) cDNAs encoding a novel high-voltage-activating, TEA-sensitive, type-A K+ channel. 1992, Pubmed , Xenbase
Wang, Modulation by clamping: Kv4 and KChIP interactions. 2008, Pubmed
Xie, Closed-state inactivation in Kv4.3 isoforms is differentially modulated by protein kinase C. 2009, Pubmed , Xenbase
Xu, Assembly of voltage-gated potassium channels. Conserved hydrophilic motifs determine subfamily-specific interactions between the alpha-subunits. 1995, Pubmed
Ziaeian, Epidemiology and aetiology of heart failure. 2016, Pubmed
Zicha, Transmural expression of transient outward potassium current subunits in normal and failing canine and human hearts. 2004, Pubmed